Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Study ID
- NCT01137643
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Not accepted
Interventions
- biologic sample preservation procedure — OTHERAll samples collected during routine clinical care.
- cytology specimen collection procedure — OTHERAll Samples collected during routine clinical care.
Study Details
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Key Dates
- Start date
- Jul 31, 2009
- Status verified
- Oct 2025
- Primary completion
- Jul 31, 2040
- Completion
- Jul 31, 2040
Study Design
- Enrollment
- 15,000 participants (estimated)
Primary Outcome Measure
Tissue, blood, and body fluid samples collection for ongoing diagnostic, prognostic, or immune-monitoring studies [ Time Frame: 30 years ]
Central Contacts
- Paul Armistead, MD(919) 843-6847
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill | Chapel Hill | North Carolina | 27599-7295 | Tissue Procurement Facility 919-966-2620 |
Find similar trials in Chapel Hill, NC
By condition
By specialty
Related Studies
- Registry of Older Patients With CancerRecruiting · UNC Lineberger Comprehensive Cancer Center · Boone, North Carolina
- The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative RegimenRecruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 MutationPHASE1 · Recruiting · Institut de Recherches Internationales Servier · Birmingham, Alabama